Literature DB >> 21324527

The immunostimulatory activity of phosphorothioate CpG oligonucleotides is affected by distal sequence changes.

Tara L Roberts1, Jasmyn A Dunn, Matthew J Sweet, David A Hume, Katryn J Stacey.   

Abstract

CpG motifs in bacterial DNA activate innate immune cells via toll like receptor 9 (TLR9). Short synthetic oligodeoxynucleotides (ODN) containing a six base CpG motif can mimic the immunostimulatory activity of bacterial DNA. Phosphorothioate (PS) modification of the backbone of ODN makes them more resistant to nuclease degradation and consequently preferable for therapeutic use. Previous studies have shown that the sequence requirements for PS-ODN to have maximal stimulatory activity are more stringent than for normal phosphodiester (PO) ODN. Here we show small sequence changes distal to the CpG motif can affect the activity of PS-ODN whilst having no effect on the activity of PO-ODN. The addition of terminal dG residues and other minor changes to the potently immunostimulatory PS-ODN 1668S caused delayed signalling. The reduction in immunostimulatory activity of PS-ODN was associated with a delay in the activation of MAP kinases. Crown
Copyright © 2011. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21324527     DOI: 10.1016/j.molimm.2011.01.011

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  10 in total

1.  A novel role for hSMG-1 in stress granule formation.

Authors:  James A L Brown; Tara L Roberts; Renee Richards; Rick Woods; Geoff Birrell; Y C Lim; Shigeo Ohno; Akio Yamashita; Robert T Abraham; Nuri Gueven; Martin F Lavin
Journal:  Mol Cell Biol       Date:  2011-09-12       Impact factor: 4.272

2.  Smg1 haploinsufficiency predisposes to tumor formation and inflammation.

Authors:  Tara L Roberts; Uda Ho; John Luff; C Soon Lee; Simon H Apte; Kelli P A MacDonald; Liza J Raggat; Allison R Pettit; Carl A Morrow; Michael J Waters; Phil Chen; Rick G Woods; Gethin P Thomas; Liam St Pierre; Camile S Farah; Raymond A Clarke; James A L Brown; Martin F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

3.  Activation of Innate Immune Responses by a CpG Oligonucleotide Sequence Composed Entirely of Threose Nucleic Acid.

Authors:  Margaret J Lange; Donald H Burke; John C Chaput
Journal:  Nucleic Acid Ther       Date:  2018-12-11       Impact factor: 5.486

4.  DEC-205 is a cell surface receptor for CpG oligonucleotides.

Authors:  Mireille H Lahoud; Fatma Ahmet; Jian-Guo Zhang; Simone Meuter; Antonia N Policheni; Susie Kitsoulis; Chin-Nien Lee; Meredith O'Keeffe; Lucy C Sullivan; Andrew G Brooks; Richard Berry; Jamie Rossjohn; Justine D Mintern; Javier Vega-Ramos; Jose A Villadangos; Nicos A Nicola; Michel C Nussenzweig; Katryn J Stacey; Ken Shortman; William R Heath; Irina Caminschi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-17       Impact factor: 11.205

5.  Toll-Like Receptor 9-Dependent AMPKα Activation Occurs via TAK1 and Contributes to RhoA/ROCK Signaling and Actin Polymerization in Vascular Smooth Muscle Cells.

Authors:  Cameron G McCarthy; Camilla F Wenceslau; Safia Ogbi; Theodora Szasz; R Clinton Webb
Journal:  J Pharmacol Exp Ther       Date:  2018-01-18       Impact factor: 4.030

6.  DEC-205 is a cell surface receptor for CpG oligonucleotides.

Authors:  Irina Caminschi; Simone Meuter; William R Heath
Journal:  Oncoimmunology       Date:  2013-03-01       Impact factor: 8.110

7.  Effects of KLK Peptide on Adjuvanticity of Different ODN Sequences.

Authors:  Ghania Chikh; Rachel Luu; Shobhna Patel; Heather L Davis; Risini D Weeratna
Journal:  Vaccines (Basel)       Date:  2016-05-04

8.  CpG oligodeoxynucleotides inhibit the proliferation and osteoclastic differentiation of RAW264.7 cells.

Authors:  Yi Zheng; Wenwen Yu; Hongyan Li; Hongbing Lin; Zhen Chen; Huishan Chen; Peipei Zhang; Yue Tian; Xiaowei Xu; Yuqin Shen
Journal:  RSC Adv       Date:  2020-04-15       Impact factor: 4.036

9.  Insights into innate immune activation via PS-ASO-protein-TLR9 interactions.

Authors:  Adam J Pollak; Luyi Zhao; Timothy A Vickers; Ian J Huggins; Xue-Hai Liang; Stanley T Crooke
Journal:  Nucleic Acids Res       Date:  2022-08-12       Impact factor: 19.160

10.  VaccineDA: Prediction, design and genome-wide screening of oligodeoxynucleotide-based vaccine adjuvants.

Authors:  Gandharva Nagpal; Sudheer Gupta; Kumardeep Chaudhary; Sandeep Kumar Dhanda; Satya Prakash; Gajendra P S Raghava
Journal:  Sci Rep       Date:  2015-07-27       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.